viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

被引:1167
作者
Amir, El-ad David [1 ]
Davis, Kara L. [2 ]
Tadmor, Michelle D. [1 ]
Simonds, Erin F. [2 ]
Levine, Jacob H. [1 ]
Bendall, Sean C. [2 ]
Shenfeld, Daniel K. [1 ]
Krishnaswamy, Smita [1 ]
Nolan, Garry P. [2 ]
Pe'er, Dana [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, Columbia Initiat Syst Biol, New York, NY 10027 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
MINIMAL RESIDUAL DISEASE; FLOW-CYTOMETRY; MASS CYTOMETRY; STEM-CELLS; PROGENITORS; HIERARCHY; NETWORKS; BIOLOGY; GUIDE;
D O I
10.1038/nbt.2594
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
New high-dimensional, single-cell technologies offer unprecedented resolution in the analysis of heterogeneous tissues. However, because these technologies can measure dozens of parameters simultaneously in individual cells, data interpretation can be challenging. Here we present viSNE, a tool that allows one to map high-dimensional cytometry data onto two dimensions, yet conserve the high-dimensional structure of the data. viSNE plots individual cells in a visual similar to a scatter plot, while using all pairwise distances in high dimension to determine each cell's location in the plot. We integrated mass cytometry with viSNE to map healthy and cancerous bone marrow samples. Healthy bone marrow automatically maps into a consistent shape, whereas leukemia samples map into malformed shapes that are distinct from healthy bone marrow and from each other. We also use viSNE and mass cytometry to compare leukemia diagnosis and relapse samples, and to identify a rare leukemia population reminiscent of minimal residual disease. viSNE can be applied to any multi-dimensional single-cell technology.
引用
收藏
页码:545 / +
页数:10
相关论文
共 33 条
[31]   Immunophenotypic differentiation patterns of normal Hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-induced shifts [J].
van Lochem, EG ;
van der Velden, VHJ ;
Wind, HK ;
te Marvelde, JG ;
Westerdaal, NAC ;
van Dongen, JM .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 60B (01) :1-13
[32]   Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia [J].
Wakita, S. ;
Yamaguchi, H. ;
Omori, I. ;
Terada, K. ;
Ueda, T. ;
Manabe, E. ;
Kurosawa, S. ;
Iida, S. ;
Ibaraki, T. ;
Sato, Y. ;
Todoroki, T. ;
Hirakawa, T. ;
Ryotokuji, T. ;
Arai, K. ;
Kitano, T. ;
Mitamura, Y. ;
Kosaka, F. ;
Dan, K. ;
Inokuchi, K. .
LEUKEMIA, 2013, 27 (05) :1044-1052
[33]   RNA-Seq: a revolutionary tool for transcriptomics [J].
Wang, Zhong ;
Gerstein, Mark ;
Snyder, Michael .
NATURE REVIEWS GENETICS, 2009, 10 (01) :57-63